Israeli biotech Brainstorm has received a US patent for its autologous stem cell technology for the treatment of neuro-degenerative diseases. Brainstorm is preparing for its US upcoming multi-center Phase II trial with its proprietary NurOwn stem cell therapy.
http://www.brainstorm-cell.com/index.php/news-a-events/291-march-24-2014
US patent for Israeli stem cell technology
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.